SCHEMBL1241370

SCHEMBL1241370

O=C(OCc1ccccc1)c1ccc(OCCCN2CCOCC2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.64
ACHE P22303 1/20 0.64
EGFR P00533 1/20 0.62
EPHX2 P34913 2/20 0.62
KDM4E B2RXH2 4/20 0.59
NPC1 O15118 3/20 0.59
RAB9A P51151 3/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
HRH3 Q9Y5N1 4/20 0.58
CACNA1H O95180 1/20 0.58
CACNA1B Q00975 1/20 0.58
ATM Q13315 1/20 0.56
LTA4H P09960 1/20 0.56
ALDH1A1 P00352 3/20 0.55
HPGD P15428 1/20 0.55
KEAP1 Q14145 1/20 0.55
NFE2L2 Q16236 1/20 0.55
HTT P42858 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1241355 0.94 LTA4H (0.64) BCHEACHEEGFRKDM4ENPC1
SCHEMBL20981238 0.83 HTT (0.73) EGFRKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL5214308 0.83 HRH3 (0.72) KDM4ESMN1; SMN2HRH3ALDH1A1HPGD
SCHEMBL11937424 0.83 BCHE (0.76) BCHEACHEEPHX2KDM4EHRH3
SCHEMBL20981242 0.82 HTT (0.71) EGFRKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL7984700 0.82 KDM4E (0.59) EPHX2KDM4EATMLTA4HALDH1A1
SCHEMBL1242965 0.81 HRH3 (0.70) BCHEACHEEPHX2KDM4ESMN1; SMN2
SCHEMBL1497048 0.81 POLB (0.60) EGFRKDM4ESMN1; SMN2ATMALDH1A1
SCHEMBL20409779 0.81 LTA4H (0.64) EGFRKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL51012 0.80 KMT2A (0.71) RAB9AALDH1A1HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334681-A1 1,2,3,6-TETRAHYDROAZEPINO[4,5-B]INDOLE-5-CARBOXYLATE NUCLEAR RECEPTOR INHIBITORS Wyeth LLC (US) 2011-06-22 EP disclosed
US-20110039824-A1 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors WYETH (US) 2011-02-17 US disclosed
WO-2010036362-A1 1,2,3,6-TETRAHYDROAZEPINO[4,5-B]INDOLE-5-CARBOXYLATE NUCLEAR RECEPTOR INHIBITORS WYETH (US) 2010-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039824-A1 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors NR1H4, NR1H2, NR1I3 BCHE 3458/4885ACHE 4606/4885EGFR 1302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.